Inside the Practice: Inside Cancer-Immu

CancerNetwork’s Audrey Sternberg spoke with Yu Shyr, PhD, professor and chair of the Department of Biostatistics at Vanderbilt University Medical Center and director of the Vanderbilt Center for Quantitative Sciences, about Cancer-Immu, an open-access resource that uses available data to link onco-immunological genomic data and immunophenotype with biological insights that may be used for selection of immune checkpoint blockade. In the interview, Shyr discusses clinical challenges with immunotherapy use, how the developers of Cancer-Immu aim to solve these problems, and who ideal users of the platform are.